Back to Research Hub
Catalyst Pharmaceuticals, Inc.
CPRX
$31.34+0.06 (+0.19%)
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States.
StreetsValue research for Catalyst Pharmaceuticals, Inc. (CPRX)
Members get the full report for Catalyst Pharmaceuticals, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.